BioTelemetry Stock News

Wall Street brokerages forecast that BioTelemetry Inc (NASDAQ:BEAT) will post sales of $106.67 million for the current quarter, Zacks reports. Two analysts have provided estimates for BioTelemetry’s

Ladies and gentlemen, good afternoon, and thank you for joining us for the BioTelemetry Second Quarter 2020 Earnings Conference Call. Such statements involve known and unknown risks, uncertainties an

BioTelemetry (BEAT) delivered earnings and revenue surprises of 191.67% and 15.34%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

BioTelemetry, Inc. (NASDAQ:BEAT) Q2 2020 Earnings Conference Call July 30, 2020 5:00 PM ET Company Participants Joseph Capper – President and Chief Executive Officer Heather Getz – Chief Financial

Posts Strong Results and Ramps Up Business Development ActivityMALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused o

Company expands portfolio of solutions with groundbreaking insertable cardiac monitor systemMALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) Abbott Laboratories (NYSE: ABT) ABIOMED, Inc. (NASDAQ: ABMD) Adamis Pharmaceuticals Corp (NASDAQ: ADMP) Annexon...

Expands relationship to serve Centene membersMALVERN, Pa., July 29, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of

Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks. Although there were promising updates from...

MALVERN, Pa., July 23, 2020 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2020 earnings on Thursday, July 30 at 4:00 PM Eastern Time. The BioTelemetry quarterly

Advisor Group Holdings Inc. acquired a new position in BioTelemetry Inc (NASDAQ:BEAT) during the 1st quarter, according to its most recent filing with the SEC. The fund acquired 10,802 shares of the m

Royal Bank of Canada grew its stake in shares of BioTelemetry Inc (NASDAQ:BEAT) by 353.2% in the first quarter, Holdings Channel reports. The fund owned 47,731 shares of the medical research company�

The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.

Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes

State of Tennessee Treasury Department lifted its stake in BioTelemetry Inc (NASDAQ:BEAT) by 3.9% in the first quarter, according to the company in its most recent disclosure with the Securities and E